ArticleBMC pulmonary medicine2019

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.

Shohei Hamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.